Cyteir Therapeutics is creating breakthrough solutions to the major challenges facing cancer researchers today. Founded by Kevin Mills and Tim Romberger in 2012, Cyteir Therapeutics is backed by investors that include Celgene, Lightstone Ventures, National Institutes of Health, Novo Holdings, and Venrock and is headquartered in Cambridge.
FOUNDED:
2012
INDUSTRY:
Biopharma, Biotechnology, Pharmaceutical
FOUNDERS:
Kevin Mills, Tim Romberger
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
